Poll: Identify the Main Cause for Reverse Switching

Article

Reverse switching occurs when patients transitioned to or initiated on a biosimilar are changed to an originator product, often because of a perceived failure in the biosimilar therapy.

Which do you think is the main reason for reverse switching?

Lack of confidence in biosimilars among health care practitioners
Nocebo/failure to properly educate patients about biosimilars
Differences between biosimilars and originator agents
Lack of clear policy on managing patients with negative outcomes
Related Videos
Ha Kung Wong, JD.
Prerakkumar Parikh, PharmD
Brian Biehn
Chelsee Jensen, PharmD, BCPS
GBW 2023 webinar
Ryan Haumschild, PharmD, MS, MBA
Stephen Hanauer, MD, professor of medicine, Feinberg School of Medicine, Northwestern University,
Stephen Hanauer, MD, professor of medicine, Feinberg School of Medicine, Northwestern University,
Stephen Hanauer, MD
Stephen Hanauer, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.